Bionano Genomics/BNGO

$1.27

-2.31%
-
1D1W1MYTD1YMAX

About Bionano Genomics

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Ticker

BNGO

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

R. Erik Holmlin

Employees

405

Headquarters

San diego, United States

Bionano Genomics Metrics

BasicAdvanced
$45.44M
Market cap
-
P/E ratio
-$6.98
EPS
2.36
Beta
-
Dividend rate

What the Analysts think about Bionano Genomics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
608.66% upside
High $14.00
Low $6.00
$1.27
Current price
$9.00
Average price target

Bionano Genomics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,209.67% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$9.3M
8.14%
Net income
$-112.5M
189.2%
Profit margin
-1,209.67%
167.44%

Bionano Genomics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 231.96%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$1.30
-$1.20
-$1.24
-$3.22
-
Expected
-$1.10
-$1.10
-$1.03
-$0.97
-$0.87
Surprise
18.18%
9.09%
20%
231.96%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Bionano Genomics stock

Buy or sell Bionano Genomics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing